In high melanoma incidence areas, genetic counseling and CDKN2A testing are recommended for individuals with three or more primary invasive melanomas or families with at least one invasive melanoma and two more cases of melanoma and/or pancreatic cancer among first- or second-degree relatives on the same side of the family [191]. This evidence concerns the gene CDKN2A and pancreatic neoplasm.